KSILINK
Ksilink is a deeptech company specializing in patient-based drug discovery. They design and apply patient-derived cellular disease models and complex cellular systems for large-scale phenotypic screening to support partners and customers. Their proprietary drug discovery engine utilizes AI-boosted cellular profiling technologies to identify druggable targets and develop efficient compounds for novel treatments, aiming to derisk next-generation medicines for neurological diseases. Ksilink also offers tailored solutions, including assay development and complete package solutions from assay development to target identification, for handling complex cellular systems.
KSILINK
Ksilink is a deeptech company specializing in patient-based drug discovery. They design and apply patient-derived cellular disease models and complex cellular systems for large-scale phenotypic screening to support partners and customers. Their proprietary drug discovery engine utilizes AI-boosted cellular profiling technologies to identify druggable targets and develop efficient compounds for novel treatments, aiming to derisk next-generation medicines for neurological diseases. Ksilink also offers tailored solutions, including assay development and complete package solutions from assay development to target identification, for handling complex cellular systems.